Subjects and study design
T2DM
TYPE 2 DIABETES MELLITUS
A single-center, randomized, crossover, open-label study on 39 patients living with Type 2 Diabetes Mellitus (T2DM) was carried out by the Endocrinology Department of Hospital Son Llàtzer (Balearic Islands, Spain). Patients were randomly allocated to one of two cohorts: one was put on a diet plan with InsP6 supplementation for 12 weeks, while the other was put on an identical diet plan without InsP6 treatment. Following that, each group was given a 12-week washout period before switching to the other procedure for another 12-week period. Finally, all patients were followed for another 12 weeks (Fig. 